SELLAS Life Sciences Grou...

NASDAQ: SLS · Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.62
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

SELLAS Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1M n/a n/a 1M -7.6M n/a 1.9M 5.7M
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 158K 87K 123K 207K 82K 100K 1.27M n/a 100K 100K
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a -158K -87K -1.12M -207K -82K 900K -8.87M n/a 1.8M 5.6M
Operating Income
-6.87M -6.06M -6.92M -7.33M -7.62M -9.64M -8.18M -9.36M -9.05M -11.28M -9.45M -7.15M -8.62M -16.73M -11.62M -6.98M -4.45M -2.25M
Interest Income
272K 250K 181K 221K 151K 79K 41K 94K 208K 182K 158K 111K 46K 2K n/a 2K 2K 2K
Pretax Income
-6.6M -5.81M -6.74M -7.11M -7.47M -9.57M -8.14M -9.27M -8.84M -11.1M -9.12M -7.02M -8.41M -16.74M -6.83M -7.08M -4.61M -2.4M
Net Income
-6.6M -5.81M -6.74M -7.11M -7.47M -9.57M -8.14M -9.27M -8.84M -11.1M -9.12M -7.02M -8.41M -16.74M -6.6M -7.08M -4.61M -2.4M
Selling & General & Admin
3M 2.86M 2.48M 2.97M 2.44M 4.53M 3.08M 3.55M 3.13M 4.11M 3.6M 2.86M 3.09M 3.02M 2.53M 2.44M 2.8M 3.56M
Research & Development
3.87M 3.21M 4.44M 4.36M 5.19M 5.11M 5.1M 5.81M 5.92M 7.17M 5.85M 4.28M 5.53M 14.61M 9.09M 4.54M 3.46M 4.28M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.79M n/a n/a 10M 5.9M n/a n/a n/a
Operating Expenses
6.87M 6.06M 6.92M 7.33M 7.62M 9.64M 8.18M 9.36M 9.05M 11.28M 9.45M 7.15M 8.62M 17.64M 11.62M 6.98M 6.25M 7.84M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.87M 6.06M 6.92M 7.33M 7.62M 9.64M 8.18M 9.36M 9.05M 11.28M 9.45M 7.15M 8.62M 7.74M 11.62M 6.98M 6.35M 7.95M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 7K -237K -2K -2K -2K
Shares Outstanding (Basic)
98.56M 87.76M 612.02M 68.25M 57.63M 403.32M 32.13M 255.2M 255.13M 211.93M 189.05M 185.06M 182.58M 143.08M 142.87M 15.87M 137.43M 133.9M
Shares Outstanding (Diluted)
98.56M 87.76M 612.02M 68.25M 57.63M 403.32M 32.13M 255.2M 255.13M 211.93M 189.05M 185.06M 182.58M 143.08M 142.87M 15.87M 137.43M 133.9M
EPS (Basic)
-0.07 -0.07 -0.01 -0.1 -0.13 -0.21 -0.25 -0.04 -0.03 -0.05 -0.05 -0.04 -0.41 -0.12 -0.05 -0.45 -0.3 -0.02
EPS (Diluted)
-0.07 -0.07 -0.01 -0.1 -0.13 -0.21 -0.25 -0.04 -0.03 -0.05 -0.05 -0.04 -0.41 -0.12 -0.05 -0.45 -0.3 -0.02
EBITDA
-6.6M -6.06M -16.38M -7.33M -7.62M -9.01M -8.14M -9.27M -9.05M -11.28M -9M -6.82M -8.33M -16.73M -11.62M -6.98M -4.45M -1.56M
EBIT
-6.6M -6.06M -6.74M -7.33M -7.62M -9.57M -8.14M -9.27M -8.84M -11.1M -9.12M -7.15M -8.62M -16.74M -11.62M -7.08M -4.61M -2.25M
Depreciation & Amortization
n/a n/a -9.64M n/a n/a 9.64M n/a n/a 158K 87K 123K 207K 82K 45K 1.27M 6.98M 4.45M 846K